PD-L1 Expression in Lung Cancer

Clinical trial NCT04992715 · UNKNOWN

Trial details

NCT number: NCT04992715
Sponsor: NanoMab Technology (UK) Limited
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2022-05-03
Primary completion: 2023-09-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.